| KT group n = 25 | placebo group n = 25 | p-Value |
---|---|---|---|
Agea | 57.2 ± 6.62 | 57.12 ± 8.88 | 0.97 |
Female genderb | 23 (92%) | 23 (92%) | > 0.99 |
Affected side | Â | Â | 0.15 |
 • Rightb | 10 (40%) | 15 (60%) |  |
 • Left b | 15 (60%) | 10 (40%) |  |
Symptoms duration (month)3 | 6 [2.5–12] | 12 [4.5–12] | 0.33 |
Echography findings | |||
 • Tendinitisb | 6 (24%) | 5 (20%) | 0.86 |
 • Bursitisb | 9 (36%) | 9 (36%) | > 0.99 |
 • Calcificationb | 3 (12%) | 5 (20%) | 0.44 |
 • Partial tearb | 7 (28%) | 8 (32%) | 0.75 |
Baseline DASHa | 41.6 ± 10.84 | 44.5 ± 12.67 | 0.39 |